Literature DB >> 20125169

Immunology: TL1A in the inflammatory network in autoimmune diseases.

Jagadeesh Bayry1.   

Abstract

Several lines of evidence both from experimental models and from clinical studies reveal that TNF-like ligand 1A (TL1A) and its interaction with death receptor 3 (DR3) is critically involved in the pathogenesis of rheumatoid arthritis and other autoimmune diseases.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20125169     DOI： 10.1038/nrrheum.2009.263

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  10 in total

1.  TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.

Authors:  Thi Sau Migone; Jun Zhang; Xia Luo; Li Zhuang; Cecil Chen; Bugen Hu; June S Hong; James W Perry; Su Fang Chen; Joe X H Zhou; Yun Hee Cho; Stephen Ullrich; Palanisamy Kanakaraj; Jeffrey Carrell; Ernest Boyd; Henrik S Olsen; Gang Hu; Laurie Pukac; Ding Liu; Jian Ni; Sunghee Kim; Reiner Gentz; Ping Feng; Paul A Moore; Steve M Ruben; Ping Wei
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

2.  Death receptor 3 (DR3) gene duplication in a chromosome region 1p36.3: gene duplication is more prevalent in rheumatoid arthritis.

Authors:  K Osawa; N Takami; K Shiozawa; A Hashiramoto; S Shiozawa
Journal:  Genes Immun       Date:  2004-09       Impact factor: 2.676

3.  Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.

Authors:  Giorgos Bamias; Charles Martin; Marco Marini; Sharon Hoang; Margarita Mishina; William G Ross; Muhammadreza A Sachedina; Charles M Friel; James Mize; Stephen J Bickston; Theresa T Pizarro; Ping Wei; Fabio Cominelli
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

4.  Role of TL1A in the pathogenesis of rheumatoid arthritis.

Authors:  Jun Zhang; Xuehai Wang; Hassan Fahmi; Susan Wojcik; James Fikes; Youhua Yu; Jiangping Wu; Hongyu Luo
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

5.  Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.

Authors:  Shinya Hayashi; Yasushi Miura; Takayuki Nishiyama; Makoto Mitani; Koji Tateishi; Yoshitada Sakai; Akira Hashiramoto; Masahiro Kurosaka; Shunichi Shiozawa; Minoru Doita
Journal:  Arthritis Rheum       Date:  2007-04

6.  Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis.

Authors:  Marco A Cassatella; Gabriela Pereira-da-Silva; Gabriela Pereira da Silva; Ilaria Tinazzi; Fabio Facchetti; Patrizia Scapini; Federica Calzetti; Nicola Tamassia; Ping Wei; Bernardetta Nardelli; Viktor Roschke; Annunciata Vecchi; Alberto Mantovani; Lisa M Bambara; Steven W Edwards; Antonio Carletto
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

7.  Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis.

Authors:  Giorgos Bamias; Spyros I Siakavellas; Kimon S Stamatelopoulos; Elda Chryssochoou; Christos Papamichael; Petros P Sfikakis
Journal:  Clin Immunol       Date:  2008-08-30       Impact factor: 3.969

8.  The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.

Authors:  Françoise Meylan; Todd S Davidson; Erin Kahle; Michelle Kinder; Krishika Acharya; Dragana Jankovic; Virgilio Bundoc; Marcus Hodges; Ethan M Shevach; Andrea Keane-Myers; Eddie C Y Wang; Richard M Siegel
Journal:  Immunity       Date:  2008-06-19       Impact factor: 31.745

9.  TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease.

Authors:  Bhanu P Pappu; Anna Borodovsky; Timothy S Zheng; Xuexian Yang; Ping Wu; Xingwen Dong; Shawn Weng; Beth Browning; Martin L Scott; Li Ma; Lihe Su; Qiang Tian; Pascal Schneider; Richard A Flavell; Chen Dong; Linda C Burkly
Journal:  J Exp Med       Date:  2008-04-14       Impact factor: 14.307

10.  The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis.

Authors:  Melanie Jane Bull; Anwen Siân Williams; Zarabeth Mecklenburgh; Claudia Jane Calder; Jason Peter Twohig; Carole Elford; Bronwen Alice James Evans; Tania F Rowley; Tomasz J Slebioda; Vadim Y Taraban; Aymen Al-Shamkhani; Eddie Chung Yern Wang
Journal:  J Exp Med       Date:  2008-09-29       Impact factor: 14.307
  10 in total
  17 in total

1.  Human primary biliary cirrhosis-susceptible allele of rs4979462 enhances TNFSF15 expression by binding NF-1.

Authors:  Yuki Hitomi; Minae Kawashima; Yoshihiro Aiba; Nao Nishida; Mika Matsuhashi; Hitoshi Okazaki; Minoru Nakamura; Katsushi Tokunaga
Journal:  Hum Genet       Date:  2015-04-22       Impact factor: 4.132

2.  TL1A inhibits atherosclerosis in apoE-deficient mice by regulating the phenotype of vascular smooth muscle cells.

Authors:  Dan Zhao; Jiaqi Li; Chao Xue; Ke Feng; Lipei Liu; Peng Zeng; Xiaolin Wang; Yuanli Chen; Luyuan Li; Zhisong Zhang; Yajun Duan; Jihong Han; Xiaoxiao Yang
Journal:  J Biol Chem       Date:  2020-09-22       Impact factor: 5.157

3.  Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis.

Authors:  Hiroshi Maruyama; Kouichi Hirayama; Miho Nagai; Itaru Ebihara; Homare Shimohata; Masaki Kobayashi
Journal:  Clin Rheumatol       Date:  2016-06-01       Impact factor: 2.980

4.  LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth.

Authors:  J Zhou; Z Yang; T Tsuji; J Gong; J Xie; C Chen; W Li; S Amar; Z Luo
Journal:  Oncogene       Date:  2011-01-10       Impact factor: 9.867

5.  Viscum album exerts anti-inflammatory effect by selectively inhibiting cytokine-induced expression of cyclooxygenase-2.

Authors:  Pushpa Hegde; Mohan S Maddur; Alain Friboulet; Jagadeesh Bayry; Srini V Kaveri
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

6.  Involvement of FOXO transcription factors, TRAIL-FasL/Fas, and sirtuin proteins family in canine coronavirus type II-induced apoptosis.

Authors:  Gabriella Marfè; Marco Tafani; Filomena Fiorito; Ugo Pagnini; Giuseppe Iovane; Luisa De Martino
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

7.  TL1A induces TCR independent IL-6 and TNF-α production and growth of PLZF⁺ leukocytes.

Authors:  Kirsten Reichwald; Tina Z Jørgensen; Peter Tougaard; Søren Skov
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

8.  The TNF-family cytokine TL1A inhibits proliferation of human activated B cells.

Authors:  Chiara Cavallini; Ornella Lovato; Anna Bertolaso; Luciano Pacelli; Elisa Zoratti; Elisabetta Zanolin; Mauro Krampera; Alberto Zamò; Cristina Tecchio; Marco A Cassatella; Giovanni Pizzolo; Maria T Scupoli
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

9.  Copy number variations in alternative splicing gene networks impact lifespan.

Authors:  Joseph T Glessner; Albert Vernon Smith; Saarene Panossian; Cecilia E Kim; Nagahide Takahashi; Kelly A Thomas; Fengxiang Wang; Kallyn Seidler; Tamara B Harris; Lenore J Launer; Brendan Keating; John Connolly; Patrick M A Sleiman; Joseph D Buxbaum; Struan F A Grant; Vilmundur Gudnason; Hakon Hakonarson
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

10.  Progranulin-derived Atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity.

Authors:  Cui Liu; Xing-Xia Li; Wei Gao; Wen Liu; De-Shan Liu
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.